Financial reports
10-K/A
2018 FY
Annual report (amended)
28 Mar 19
10-K
2018 FY
Annual report
13 Mar 19
10-Q
2018 Q3
Quarterly report
6 Nov 18
10-Q
2018 Q2
Quarterly report
1 Aug 18
10-Q
2018 Q1
Quarterly report
3 May 18
10-K
2017 FY
Annual report
14 Mar 18
10-Q
2017 Q3
Quarterly report
1 Nov 17
10-Q
2017 Q2
Quarterly report
2 Aug 17
10-Q
2017 Q1
Quarterly report
4 May 17
Current reports
8-K
Completion of Acquisition or Disposition of Assets
2 Apr 19
8-K
Merck to Acquire Immune Design
21 Feb 19
8-K
Departure of Directors or Certain Officers
8 Jan 19
8-K
Termination of a Material Definitive Agreement
10 Dec 18
8-K
Departure of Directors or Certain Officers
13 Nov 18
8-K
Results of Operations and Financial Condition
6 Nov 18
8-K
Immune Design Announces Program Updates & Portfolio Prioritization for G100 and CMB305
11 Oct 18
8-K
Departure of Directors or Certain Officers
4 Sep 18
8-K
Results of Operations and Financial Condition
1 Aug 18
8-K
Departure of Directors or Certain Officers
27 Jul 18
Registration and prospectus
15-12B
Securities registration termination
12 Apr 19
S-8 POS
Registration of securities for employees (post-effective amendment)
2 Apr 19
S-8 POS
Registration of securities for employees (post-effective amendment)
2 Apr 19
S-8 POS
Registration of securities for employees (post-effective amendment)
2 Apr 19
S-8 POS
Registration of securities for employees (post-effective amendment)
2 Apr 19
S-8 POS
Registration of securities for employees (post-effective amendment)
2 Apr 19
POS AM
Prospectus update (post-effective amendment)
2 Apr 19
25-NSE
Exchange delisting
2 Apr 19
SC 14D9/A
Tender offer solicitation (amended)
2 Apr 19
SC TO-T/A
Third party tender offer statement (amended)
2 Apr 19
Proxies
Other
EFFECT
Notice of effectiveness
9 Apr 19
CT ORDER
Confidential treatment order
22 Feb 19
CT ORDER
Confidential treatment order
30 Jun 17
CT ORDER
Confidential treatment order
8 May 17
CT ORDER
Confidential treatment order
13 Mar 17
CT ORDER
Confidential treatment order
12 Apr 16
EFFECT
Notice of effectiveness
29 Dec 15
CORRESP
Correspondence with SEC
28 Dec 15
UPLOAD
Letter from SEC
17 Aug 15
EFFECT
Notice of effectiveness
15 Apr 15